Brenton Karl Ahrens, Director at Iterum Therapeutics plc (ITRM), sold 33,298 shares at $2.31 ($77K) on 2022-09-12, disclosed to the SEC on 2022-09-12.
Open-market sale of $77k ITRM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.26 | 3,298 | $7K | 9.7% |
| 2 | $2.32 | 15,000 | $35K | 45.3% |
| 3 | $2.31 | 15,000 | $35K | 45.1% |
| Total | $2.31 avg | 33,298 | $77K | 100% |
| Filing → |
| ITRM | BUY | 2018-05-30 | $6.6M | — | Filing → |
| DRTX | BUY | 2012-07-26 | $5.0M | — | Filing → |
| ACTV | SELL | 2012-03-06 | $3.1M | — | Filing → |